Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

November 28, 2013

More Neurologists Now Mention Once-Daily Dosing As Aubagio’s Biggest Advantage

  • Oral MS Medications
    /
PRESS RELEASE Nov. 25, 2013, Two-Thirds of Surveyed U.S. Neurologists Have Prescribed Genzyme’s Aubagio to Their Multiple Sclerosis Patients at…
Oral MS Medications

November 25, 2013

Drug may work in PPMS

  • Additional MS resource sites
    /
MS Research Drug working for PPMS Arun T, Tomassini V, Sbardella E, de Ruiter MB, Matthews L, Leite MI, Gelineau-Morel…
Additional MS resource sites

November 25, 2013

Biogen Idec Gets European Protection For MS Drug Tecfidera – Quick Facts

  • Oral MS Medications
    /
November 22, 2013 (RTTNews.com) – Biogen Idec ( BIIB ) said Friday that the Committee for Medicinal Products for Human Use or…
Oral MS Medications

November 22, 2013

Multiple Sclerosis Genetic – Environmental Study Underway

  • MS Genetic Research
    /
Researchers Recruiting 5,000 First-Degree Relatives of People with MS for Genetic/Environmental Research Study Researchers from the Harvard Medical School, Brigham…
MS Genetic Research

November 22, 2013

Multiple Sclerosis Symptoms: 5 Signs To Watch Out For

  • Multiple Sclerosis (MS) Symptoms
    /
  • Multiple Sclerosis Videos
    /
By Connie Brichford, Everyday Health It’s more important than ever to be aware of the warning signs of multiple sclerosis,…
Multiple Sclerosis (MS) Symptoms

November 22, 2013

U.S. Claims Data Show Declining Use of Platform Injectables as Oral Multiple Sclerosis Therapies Gain Traction

  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
Nevertheless, Injectables Remain First-Line Mainstays Among Newly Diagnosed Patients, According to a New Report from Decision Resources By Decision Resources Published:…
Multiple Sclerosis

November 21, 2013

MS Treatment and Research Update

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Multiple Sclerosis (MS) Symptoms
    /
By Patricia K. Coyle, MD The 29th Congress of the European Committee for the Treatment and Research in MS (ECTRIMS)…
MS Research Study and Reports

November 19, 2013

FDA advisory committee recommends Lemtrada’s approval with restrictions; final decision by FDA to come by year’s end

  • MS Drug Therapies
    /
Posted by Editorial Team—November 14th, 2013 As discussed in Laura’s latest blog Lemtrada – Sanofi’s Request for a new MS Drug, the…
MS Drug Therapies

November 19, 2013

Blood-brain barrier disruption in multiple sclerosis

  • MS Research Study and Reports
    /
Alireza Minagar Departments of Neurology, Psychiatry and Anesthesiology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA J Steven…
MS Research Study and Reports

November 18, 2013

A Financial Wellness webinar series for people living with Multiple Scleroris (MS)

  • Additional MS resource sites
    /
A Powerful Webinar Series needed by many: Click the Above Logo to Link to Pre-recorded Webinars provided by: Acorda Therapeutics and…
Additional MS resource sites

Categories

Latest Blog Posts